CIM LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1,085
| Closed | -$780K | – | 152 |
|
2023
Q2 | $780K | Hold |
1,085
| – | – | 0.15% | 94 |
|
2023
Q1 | $892K | Sell |
1,085
-36
| -3% | -$29.6K | 0.18% | 86 |
|
2022
Q4 | $835K | Sell |
1,121
-67
| -6% | -$49.9K | 0.17% | 95 |
|
2022
Q3 | $903K | Sell |
1,188
-48
| -4% | -$36.5K | 0.19% | 88 |
|
2022
Q2 | $768K | Sell |
1,236
-33
| -3% | -$20.5K | 0.16% | 96 |
|
2022
Q1 | $917K | Buy |
+1,269
| New | +$917K | 0.17% | 88 |
|
2020
Q4 | – | Sell |
-1,100
| Closed | -$648K | – | 168 |
|
2020
Q3 | $648K | Buy |
1,100
+7
| +0.6% | +$4.12K | 0.13% | 103 |
|
2020
Q2 | $682K | Buy |
1,093
+26
| +2% | +$16.2K | 0.2% | 71 |
|
2020
Q1 | $521K | Buy |
+1,067
| New | +$521K | 0.2% | 67 |
|
2017
Q4 | – | Sell |
-978
| Closed | -$437K | – | 100 |
|
2017
Q3 | $437K | Buy |
978
+12
| +1% | +$5.36K | 0.18% | 67 |
|
2017
Q2 | $474K | Buy |
+966
| New | +$474K | 0.2% | 56 |
|